UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 163 filers reported holding UNIQURE NV in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $671 | -85.6% | 100 | -50.0% | 0.00% | – |
Q2 2023 | $4,675 | +32.5% | 200 | +100.0% | 0.00% | – |
Q1 2023 | $3,529 | +88125.0% | 100 | 0.0% | 0.00% | – |
Q4 2022 | $4 | -100.0% | 100 | -61.7% | 0.00% | -100.0% |
Q3 2022 | $22,000 | 0.0% | 261 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $22,000 | -15.4% | 261 | -27.7% | 0.00% | – |
Q1 2022 | $26,000 | +1200.0% | 361 | +261.0% | 0.00% | – |
Q4 2021 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | -40.0% | 100 | -30.1% | 0.00% | – |
Q4 2020 | $5,000 | 0.0% | 143 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | 0.0% | 143 | +43.0% | 0.00% | – |
Q2 2020 | $5,000 | -16.7% | 100 | -31.5% | 0.00% | -100.0% |
Q1 2020 | $6,000 | -45.5% | 146 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $11,000 | +175.0% | 146 | +46.0% | 0.00% | – |
Q3 2019 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |